Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Irwin Naturals Inc (OP: IWINF )

0.3600 +0.1474 (+69.33%)
Streaming Delayed Price Updated: 9:33 AM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 100
Open 0.3600
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2126
Today's Range 0.3600 - 0.3600
52wk Range 0.0505 - 1.770
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
Defense Dept. Funds Ketamine Study For PTSD Treatment  
Via Benzinga
Irwin Naturals' Bold Leap: Cannabis, Psychedelics Drive Q3 Buzz Despite Falling Revenue & Surging Losses
Irwin Naturals Inc. 
Via Benzinga
Topics Cannabis
Exposures Cannabis

Performance

YTD
+60.14%
+60.14%
1 Month
+78.75%
+78.75%
3 Month
+159.18%
+159.18%
6 Month
-15.79%
-15.79%
1 Year
-79.66%
-79.66%

More News

Read More
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
Via Benzinga
Irwin Naturals Revenue Sluggish In Q2, Net Loss Grows YOY
Via Benzinga
Irwin Naturals Launches Trio Of Cannabis Tinctures In California
Via Benzinga
Cannabis Stock Gainers And Losers From August 25, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Irwin Naturals Q1 FY23 Revenue Stagnates YoY, What About Adjusted EBITDA?
Via Benzinga
Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More
Via Benzinga
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Irwin Naturals FY22 Revenue Declines 10.8%, What About Adjusted EBITDA?
Via Benzinga
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
Via Benzinga
Marijuana Stock Movers For August 15, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Scandal And Resignation Of Oregon Official, USCC's New Leadership & More Executive Moves
Via Benzinga
Cannabis Stock Movers For August 10, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Psychedelics Company Confirms Shares Spinout, Another Fails To File Financials & Gets CTO Issue
Via Benzinga
Cantor Fitzgerald Discontinues Research Coverage Of The Cannabis Sector
Via Benzinga
Cannabis Stock Movers For July 27, 2023
Via Benzinga
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
Via Benzinga
Irwin Naturals Cannabis Products Launch Nationwide In Canada
Via Benzinga
Irwin Naturals Acquires Ketamine Media
Via Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
Via Benzinga
Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal
Via Benzinga
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend?
Via Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
Via Benzinga
Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.